GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDWF.L Regulatory News (DWF)

  • There is currently no data for DWF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: DWF Group (DWF) - Investor Forum company research (Nov 2021)

2 Dec 2021 10:35

Hardman & Co Research Hardman & Co Research: DWF Group (DWF) - Investor Forum company research (Nov 2021) 02-Dec-2021 / 10:35 GMT/BST


Hardman & Co November 2021 Investor Forum company research:

DWF Group (DWF)

On 18 November we were delighted to host our final Investor Forum of the year. At the live event, the CEO of DWF Group, Chris Stefani, engaged with the audience through the Q&A, explaining in detail its corporate culture, staff retentions, the benefits of being listed on the main market versus AIM, and the key metrics differentiating DWF from its competitors.

 We would like to share with you the research note and slide pack, along with the recording of the presentation.

Read DWF research note | Download DWF |

Watch DWF forum recording

If you are interested in meeting the company, you can register your interest by clicking here.

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Paul Singer

+44 20 3693 7075

 

ps@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1253724 02-Dec-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
3rd Apr 20201:58 pmRNSDirector/PDMR Shareholding
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 20207:00 amRNSDirector/PDMR Shareholding
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 20203:58 pmRNSDirector/PDMR Shareholding and Amendment
27th Mar 20203:29 pmRNSDirector/PDMR Shareholding
27th Mar 20207:00 amRNSCOVID-19 UPDATE
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:42 pmRNSPrice Monitoring Extension
17th Mar 20204:43 pmRNSSecond Price Monitoring Extn
17th Mar 20204:36 pmRNSPrice Monitoring Extension
5th Mar 20207:00 amRNSTotal Voting Rights
4th Mar 20209:47 amRNSConsideration Shares admitted to trading
2nd Mar 20207:00 amRNSDWF completes acquisition of Mindcrest Inc.
14th Feb 20202:01 pmRNSChange of Director's details
29th Jan 20207:01 amRNSNotice of Capital Markets Day
29th Jan 20207:00 amRNSDWF to acquire managed services business Mindcrest
23rd Jan 20207:00 amRNSDirector/PDMR Shareholding
16th Jan 20207:00 amRNSDividend Declaration
2nd Jan 202012:18 pmRNSTotal Voting Rights
24th Dec 201910:45 amRNSHolding(s) in Company
23rd Dec 20198:11 amRNSConsideration Shares admitted to trading
20th Dec 20191:47 pmRNSDWF completes acquisition of RCD
11th Dec 20197:01 amRNSDWF to acquire Spanish firm Rousaud Costas Duran
11th Dec 20197:00 amRNSDWF Group plc Half Year Results
18th Nov 20197:00 amRNSHY20 Interim Trading Statement
13th Nov 20197:00 amRNSDividend Declaration
6th Nov 20197:00 amRNSDWF continues investment in international business
22nd Oct 20197:00 amRNSNotice of Half Year Results
22nd Oct 20197:00 amRNSNotice of Trading Update
7th Oct 20199:00 amRNSDWF opens in Düsseldorf
20th Sep 20191:06 pmRNSResult of AGM
13th Sep 201911:47 amRNSDWF wins at FT Innovative Lawyers Awards
28th Aug 20199:59 amRNSDirector/PDMR Shareholding
20th Aug 20193:00 pmRNSAnnual Report & Accounts and Notice of AGM
8th Aug 20197:00 amRNSAppointment of Joint Corporate Broker
6th Aug 20197:00 amRNSTotal Voting Rights
31st Jul 20197:00 amRNSFull year results for the year ended 30 April 2019
25th Jul 20197:00 amRNSChange of Director's details
23rd Jul 20191:00 pmRNSBT appoints DWF as a strategic legal partner
1st Jul 20199:47 amRNSNotice of Full Year Results
4th Jun 20199:38 amRNSChange of Director's details
3rd Jun 20197:05 amRNSAppointment of Joint Corporate Brokers
3rd Jun 20197:00 amRNSFY19 Trading Statement
2nd May 20197:00 amRNSDWF to acquire legal services business
18th Mar 20199:31 amRNSDirector/PDMR Shareholding
15th Mar 20198:04 amRNSAdmission to Trading on the London Stock Exchange
14th Mar 20197:00 amRNSRe-registration as plc and change of name
11th Mar 20191:11 pmRNSPublication of a Prospectus
11th Mar 20197:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.